EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms

Razieh Kebriaei, Susan M Lehman, Rahi M Shah, Kyle C Stamper, Ashlan J Kunz Coyne, Dana Holger, Amer El Ghali, Michael J Rybak iD

Microbiology Spectrum · 15.06.2023 · 11 (3)

DOI: 10.1128/spectrum.04918-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 15.06.2023. Verfasst von Razieh Kebriaei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Anti-Infective Research Laboratory, College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Bacteriophages, Staphylococcal Infections, Daptomycin. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The extracellular polymeric matrix of biofilms presents an impediment to antibiotic diffusion, facilitating the emergence of multidrug-resistant populations. While most phage cocktails are designed for the planktonic state of bacteria, it is important to take the biofilm mode of growth (the predominant mode of bacterial growth in nature) into consideration, as it is unclear how interactions between any specific phage and its bacterial hosts will depend on the physical properties of the growth environment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusBacteriophagesStaphylococcal InfectionsDaptomycinHumansStaphylococcus aureusAnti-Bacterial AgentsBiofilmsVancomycinMicrobial Sensitivity Tests

Stichwörter der Autor:innen

MRSAbacteriophagesbiofilms

Substanzen

Anti-Bacterial AgentsVancomycinDaptomycin

Autor:innen und Institutionen

  • Anti-Infective Research Laboratory, College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.
  • Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • School of Medicine, Wayne State University, Detroit, Michigan, USA.

ORCID-Profile: Michael J Rybak

Förderung

  • NIAID NIH HHS
  • HHS | National Institutes of Health

Zitieren

APA

Kebriaei, R., Lehman, S. M., Shah, R. M., Stamper, K. C., Kunz Coyne, A. J., Holger, D., El Ghali, A., & Rybak, M. J. (2023). Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms. Microbiology Spectrum, 11(3). https://doi.org/10.1128/spectrum.04918-22

Vancouver

Kebriaei R, Lehman SM, Shah RM, Stamper KC, Kunz Coyne AJ, Holger D, et al. Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms. Microbiology Spectrum. 2023;11(3). doi:10.1128/spectrum.04918-22

BibTeX
@article{Kebriaei2023,
  author = {Kebriaei, Razieh and Lehman, Susan M and Shah, Rahi M and Stamper, Kyle C and Kunz Coyne, Ashlan J and Holger, Dana and El Ghali, Amer and Rybak, Michael J},
  title = {Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms},
  journal = {Microbiology Spectrum},
  year = {2023},
  volume = {11},
  number = {3},
  doi = {10.1128/spectrum.04918-22}
}
Kostenlos starten →